Corporate law

IsZo Capital Comments on Nam Tai’s Appointment of Three Kaisa-Affiliated Individuals to Key Leadership Roles

Tuesday, September 22, 2020 - 5:15pm

IsZo recently announced that it delivered to Nam Tai verified requests to convene a meeting of Nam Tai shareholders (the Special Meeting) from holders of more than 40% of the Companys outstanding shares.

Key Points: 
  • IsZo recently announced that it delivered to Nam Tai verified requests to convene a meeting of Nam Tai shareholders (the Special Meeting) from holders of more than 40% of the Companys outstanding shares.
  • It is time for the Kaisa-controlled Board to realize that no amount of cosmetic, reactionary changes will pacify long-suffering shareholders.
  • Nam Tais current leadership continues to contradict itself and demonstrate a fundamental disregard for acceptable corporate governance and honest investor communication.
  • We also encourage shareholders to learn more about our slate and its strategic vision by visiting at www.FixNTP.com .

Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments

Tuesday, September 22, 2020 - 12:00pm

Ms. Giles will serve as a member of the Audit Committee of the Board and Dr. Wills will serve as a member of the Nominating & Corporate Governance Committee of the Board.

Key Points: 
  • Ms. Giles will serve as a member of the Audit Committee of the Board and Dr. Wills will serve as a member of the Nominating & Corporate Governance Committee of the Board.
  • "On behalf of the entire Board of Directors, it is a pleasure to welcome Lisa and Rob, two highly accomplished industry veterans, to our team," said Joseph Oliveto, President and Chief Executive Officer of Milestone Pharmaceuticals.
  • Ms. Giles brings to the Milestone Board of Directors over 35 years of experience in the pharmaceutical industry, including strategic planning, operations, and business development.
  • He was previously a member of the Board of Directors of GTx, Inc., where he served as Executive Chairman and Chair of the Scientific and Development Committee.

Nomination Committee appointed for Electrolux Annual General Meeting 2021

Tuesday, September 22, 2020 - 7:25am

STOCKHOLM, Sept. 22, 2020 /PRNewswire/ -- In accordance with decision by the Annual General Meeting, Electrolux Nomination Committee shall consist of six members.

Key Points: 
  • STOCKHOLM, Sept. 22, 2020 /PRNewswire/ -- In accordance with decision by the Annual General Meeting, Electrolux Nomination Committee shall consist of six members.
  • The members of the Nomination Committee have now been appointed based on the ownership structure as of August 31, 2020.
  • The Nomination Committee will prepare proposals for the Annual General Meeting in 2021 regarding Chairman of the Annual General Meeting, Board members, Chairman of the Board, remuneration for Board members, Auditor, Auditor's fees and, to the extent deemed necessary, proposal regarding amendments of the current instruction for the Nomination Committee.
  • The Annual General Meeting will be held on March 25, 2021, in Stockholm, Sweden.

Nomination Committee appointed for Electrolux Annual General Meeting 2021

Tuesday, September 22, 2020 - 7:21am

STOCKHOLM, Sept. 22, 2020 /PRNewswire/ -- In accordance with decision by the Annual General Meeting, Electrolux Nomination Committee shall consist of six members.

Key Points: 
  • STOCKHOLM, Sept. 22, 2020 /PRNewswire/ -- In accordance with decision by the Annual General Meeting, Electrolux Nomination Committee shall consist of six members.
  • The members of the Nomination Committee have now been appointed based on the ownership structure as of August 31, 2020.
  • The Nomination Committee will prepare proposals for the Annual General Meeting in 2021 regarding Chairman of the Annual General Meeting, Board members, Chairman of the Board, remuneration for Board members, Auditor, Auditor's fees and, to the extent deemed necessary, proposal regarding amendments of the current instruction for the Nomination Committee.
  • The Annual General Meeting will be held on March 25, 2021, in Stockholm, Sweden.

SWEF: Transaction in Own Shares

Tuesday, September 22, 2020 - 7:01am

Following the purchase of these shares, the Company will have 413,219,398 shares in issue.

Key Points: 
  • Following the purchase of these shares, the Company will have 413,219,398 shares in issue.
  • The Company holds 1,257,000 shares in treasury.
  • Therefore, the total number of voting rights in the Company is 411,962,398, which may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

Canopy Growth Announces Results of Annual General and Special Meeting of Shareholders

Monday, September 21, 2020 - 11:45pm

At the Meeting, Canopy Growth shareholders approved the appointment of KPMG LLP as the Company's auditors for the 2021 fiscal year and authorized the board of directors to fix its remuneration.

Key Points: 
  • At the Meeting, Canopy Growth shareholders approved the appointment of KPMG LLP as the Company's auditors for the 2021 fiscal year and authorized the board of directors to fix its remuneration.
  • Canopy Growth shareholders also approved advisory (non-binding) resolutions on the compensation of the Company's named executive officers and to hold "say-on-pay" votes each year.
  • A report of voting results on all resolutions voted on at the Meeting will be available on both the Company's EDGAR and SEDAR pages at www.sec.gov/edgar and www.sedar.com , respectively.
  • Canopy Growth operates retail stores across Canada under its award-winning Tweed and Tokyo Smoke banners.

ESAs launch survey on environmental and/or social financial product templates

Tuesday, September 22, 2020 - 12:08am

The European Supervisory Authorities (EBA, EIOPA and ESMA - ESAs) published today a survey seeking public feedback on presentational aspects of product templates, pursuant to Article 8(3), Article 9(5) and Article 11(4) of the Regulation on sustainabilityrelated disclosures in the financial services (SFDR).

Key Points: 
  • The European Supervisory Authorities (EBA, EIOPA and ESMA - ESAs) published today a survey seeking public feedback on presentational aspects of product templates, pursuant to Article 8(3), Article 9(5) and Article 11(4) of the Regulation on sustainabilityrelated disclosures in the financial services (SFDR).
  • The survey is open for comments until 16 October 2020.
  • The ESAs propose to standardise the disclosure of information for financial products that promote environmental and/or social characteristics or have a sustainable objective.
  • The final content of the templates is subject to the outcome of a concurrent consumer testing exercise and the ESAs final report on the draft RTS under SFDR.

ESAs launch survey on environmental and/or social financial product templates

Tuesday, September 22, 2020 - 12:07am

21 September 2020

Key Points: 
  • 21 September 2020

    Fund Management

    Joint Committee

    Sustainable finance

    The European Supervisory Authorities (EBA, EIOPA and ESMA - ESAs) published today a survey seeking public feedback on presentational aspects of product templates, pursuant to Article 8(3), Article 9(5) and Article 11(4) of the Regulation on sustainabilityrelated disclosures in the financial services (SFDR).

  • The survey is open for comments until 16 October 2020.
  • The ESAs propose to standardise the disclosure of information for financial products that promote environmental and/or social characteristics or have a sustainable objective.
  • The final content of the templates is subject to the outcome of a concurrent consumer testing exercise and the ESAs final report on the draft RTS under SFDR.

ESAs launch survey on environmental and/or social financial product templates

Tuesday, September 22, 2020 - 12:04am

21 September 2020

Key Points: 
  • 21 September 2020

    Fund Management

    Joint Committee

    Sustainable finance

    The European Supervisory Authorities (EBA, EIOPA and ESMA - ESAs) published today a survey seeking public feedback on presentational aspects of product templates, pursuant to Article 8(3), Article 9(5) and Article 11(4) of the Regulation on sustainabilityrelated disclosures in the financial services (SFDR).

  • The survey is open for comments until 16 October 2020.
  • The ESAs propose to standardise the disclosure of information for financial products that promote environmental and/or social characteristics or have a sustainable objective.
  • The final content of the templates is subject to the outcome of a concurrent consumer testing exercise and the ESAs final report on the draft RTS under SFDR.

SHAREHOLDER ALERT: Investigation of Legend Biotech Announced by Holzer & Holzer, LLC

Monday, September 21, 2020 - 10:44pm

Holzer & Holzer, LLC is investigating whether Legend Biotech Corporation (Legend Biotech or the Company) (NASDAQ: LEGN) complied with federal securities laws.

Key Points: 
  • Holzer & Holzer, LLC is investigating whether Legend Biotech Corporation (Legend Biotech or the Company) (NASDAQ: LEGN) complied with federal securities laws.
  • Legend Biotech also disclosed that the Chinese Customs Anti-Smuggling Department has inspected certain business facilities of Legend Biotech's parent and majority shareholder, including Legend Biotechs location in Nanjing, in connection with an investigation relating to suspected violations of import and export regulations under Chinese law.
  • Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation.
  • Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey D. Holzer is the attorney responsible for its content.